Zobrazeno 1 - 10
of 194
pro vyhledávání: '"D. Wool"'
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/2d5a133bb6d44d579caec49d2188f508
Autor:
Gregory W. Roloff, Frank Wen, Aubrianna Ramsland, Andrew S. Artz, Satyajit Kosuri, Wendy Stock, Olatoyosi Odenike, Richard A. Larson, Hongtao Liu, Lucy A. Godley, Michael J. Thirman, Anand A. Patel, Christopher K. Daugherty, Adam S. DuVall, Mariam T. Nawas, Emily Dworkin, Geoffrey D. Wool, Sandeep Gurbuxani, Carrie Fitzpatrick, Jeremy P. Segal, Peng Wang, Michael W. Drazer
Publikováno v:
Haematologica, Vol 108, Iss 8 (2023)
Externí odkaz:
https://doaj.org/article/1d4372d7237e4993adbe87d1b89ac577
Autor:
Adam J. Kanack, Curtis G. Jones, Bandana Singh, Rachel R. Leger, Noah P. Splinter, Nahla M. Heikal, Rajiv K. Pruthi, Dong Chen, Gemlyn George, Mouhamed Y. Abou-Ismail, Geoffrey D. Wool, Krishna Gundabolu, Anand Padmanabhan
Publikováno v:
Blood. 140:2722-2729
Heparin-induced thrombocytopenia (HIT) is suspected much more often than it is confirmed. Technically simple platelet factor 4 (PF4)-polyanion enzyme-linked immunosorbent assays (ELISAs) are sensitive but nonspecific. In contrast, accurate functional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ba8999f3c9000e4d4f31b01fb648c51
https://doi.org/10.1182/blood.2022017283
https://doi.org/10.1182/blood.2022017283
Autor:
Amrita Sarkar, Sanjay Khandelwal, Gavin Koma, Hyunjun Kim, Yves Gruel, Jerome Rollin, Freda H Passam, Geoffrey D. Wool, Gowthami M. Arepally, Douglas B. Cines, Lubica Rauova, Mortimer Poncz
Publikováno v:
Blood Advances.
Heparin-induced thrombocytopenia (HIT) is characterized by thrombocytopenia associated with a highly prothrombotic state due to the development of pathogenic antibodies that recognize human (h) platelet factor 4 (PF4) complexed with various polyanion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e637889b58ec11f328f421add86af815
https://doi.org/10.1182/bloodadvances.2023009661
https://doi.org/10.1182/bloodadvances.2023009661
Autor:
Christine Fuja, Vishesh Kothary, Timothy Clifford Carll, Savita Singh, Paul Mansfield, Geoffrey D. Wool
Publikováno v:
Transfusion. 62:1446-1451
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5206c5fc468f10c825f2dbf828152f7c
https://doi.org/10.1111/trf.16932
https://doi.org/10.1111/trf.16932
Autor:
Daniel Mansour, Alexey Dimov, Geoffrey D. Wool, Yuanyuan Zha, Samuel A. Hendley, Erin Snoddy, Steffen Sammet, Osman Ahmed, Jonathan Paul, Aarushi Bhargava, Z Lu, Rana O. Afifi, Kenneth B. Bader
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Scientific Reports
Scientific Reports
Venous thromboembolism is a significant source of morbidity and mortality worldwide. Catheter-directed thrombolytics is the primary treatment used to relieve critical obstructions, though its efficacy varies based on the thrombus composition. Non-res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a24e2c4ac6ccef3acfa244cc7d468d66
https://doaj.org/article/e5f990347bec4bce8ca156ca2a07b3d5
https://doaj.org/article/e5f990347bec4bce8ca156ca2a07b3d5
Autor:
Clarence W Chan, Chancey Christenson, Fatima Aldarweesh, Geoffrey D. Wool, Ajay Major, Kenneth S. Cohen, Timothy Carll
Publikováno v:
Journal of Clinical Apheresis. 37:117-121
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a newly described hematologic disorder, which presents as acute thrombocytopenia and thrombosis after administration of the ChAdOx1 nCov-19 (AstraZeneca) and Ad26.COV2.S (Johnson & Johnson)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73abdc3104a2f2cb614164d8ef87f4ed
https://doi.org/10.1002/jca.21945
https://doi.org/10.1002/jca.21945
Autor:
Amrita Sarkar, Sanjay Khandelwal, Hyunjun Kim, Yves Gruel, Jerome Rollin, Geoffrey D. Wool, Gowthami M. Arepally, Douglas B. Cines, Lubica Rauova, Mortimer Poncz
Heparin-induced thrombocytopenia (HIT) is characterized by mild thrombocytopenia associated with a highly prothrombotic state due to the development of pathogenic antibodies that recognize human (h) platelet factor 4 (PF4) complexed with various poly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21648c3f878937983d550c5733025277
https://doi.org/10.1101/2022.10.19.512755
https://doi.org/10.1101/2022.10.19.512755
Autor:
Gregory W. Roloff, Frank Wen, Aubrianna Ramsland, Andrew S. Artz, Satyajit Kosuri, Wendy Stock, Olatoyosi Odenike, Richard A. Larson, Hongtao Liu, Lucy A. Godley, Michael J. Thirman, Anand A. Patel, Christopher K. Daugherty, Adam S. DuVall, Mariam T. Nawas, Emily Dworkin, Geoffrey D. Wool, Carrie Fitzpatrick, Jeremy P. Segal, Peng Wang, Michael W. Drazer
The treatment of acute myeloid leukemia (AML) has been enhanced by the development and regulatory approval of a series of novel agents, including midostaurin and gilteritinib (FLT3 inhibitors), venetoclax (BCL2 inhibitor), ivosidenib (IDH1 inhibitor)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be6dffeb4a8f8b493f983208737450e5
https://doi.org/10.1101/2022.09.15.22279953
https://doi.org/10.1101/2022.09.15.22279953
Autor:
Eric Salazar, Thomas A. Long, Kristi Johnson Smock, Geoffrey D. Wool, Marian Rollins-Raval, Dong Chen, Neil Selwyn Harris, Clarence W. Chan, John D. Olson, Huy P. Pham, Jacob Ritter, David Unold, Amanda Matzke VanSandt, Andrew Jackson Goodwin IV
Publikováno v:
Seminars in Thrombosis and Hemostasis.
Von Willebrand factor (VWF) level and/or function is altered in von Willebrand disease (VWD), the most common heritable bleeding disorder worldwide. Laboratory assessment of VWF is continually evolving. Historically, the primary method for the assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6f736b59be074b69737933b5706e034
https://doi.org/10.1055/s-0042-1749591
https://doi.org/10.1055/s-0042-1749591